Gf-Fund-Management-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
Manager Name
Gf-Fund-Management-Co
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions • $4.3B total value
Manager:
Search and click to pin securities to the top
Page 27 of 34
Safehold Inc.
Shares:871
Value:$16.3K
% of Portfolio:0.0% ($16.3K/$4.3B)
ArriVent BioPharma, Inc.
Shares:863
Value:$16.0K
% of Portfolio:0.0% ($16.0K/$4.3B)
CureVac N.V.
Shares:5.7K
Value:$15.9K
% of Portfolio:0.0% ($15.9K/$4.3B)
ROCKET PHARMACEUTICALS, INC.
Shares:2.3K
Value:$15.6K
% of Portfolio:0.0% ($15.6K/$4.3B)
ANAPTYSBIO, INC
Shares:779
Value:$14.5K
% of Portfolio:0.0% ($14.5K/$4.3B)
KalVista Pharmaceuticals, Inc.
Shares:1.2K
Value:$14.4K
% of Portfolio:0.0% ($14.4K/$4.3B)
CASTLE BIOSCIENCES INC
Shares:716
Value:$14.3K
% of Portfolio:0.0% ($14.3K/$4.3B)
Paramount Group, Inc.
Shares:3.3K
Value:$14.0K
% of Portfolio:0.0% ($14.0K/$4.3B)
MeiraGTx Holdings plc
Shares:2.0K
Value:$13.6K
% of Portfolio:0.0% ($13.6K/$4.3B)
uniQure N.V.
Shares:1.2K
Value:$13.2K
% of Portfolio:0.0% ($13.2K/$4.3B)
Kura Oncology, Inc.
Shares:2.0K
Value:$13.1K
% of Portfolio:0.0% ($13.1K/$4.3B)
Plymouth Industrial REIT, Inc.
Shares:766
Value:$12.5K
% of Portfolio:0.0% ($12.5K/$4.3B)
GLADSTONE COMMERCIAL CORP
Shares:832
Value:$12.5K
% of Portfolio:0.0% ($12.5K/$4.3B)
Sage Therapeutics, Inc.
Shares:1.6K
Value:$12.4K
% of Portfolio:0.0% ($12.4K/$4.3B)
Trevi Therapeutics, Inc.
Shares:2.0K
Value:$12.4K
% of Portfolio:0.0% ($12.4K/$4.3B)
ARVINAS, INC.
Shares:1.8K
Value:$12.3K
% of Portfolio:0.0% ($12.3K/$4.3B)
OMEROS CORP
Shares:1.5K
Value:$12.2K
% of Portfolio:0.0% ($12.2K/$4.3B)
Savara Inc
Shares:4.4K
Value:$12.2K
% of Portfolio:0.0% ($12.2K/$4.3B)
Tyra Biosciences, Inc.
Shares:1.3K
Value:$12.1K
% of Portfolio:0.0% ($12.1K/$4.3B)
DTE ENERGY CO
Shares:87
Value:$12.0K
% of Portfolio:0.0% ($12.0K/$4.3B)